Abstract:
The first cladding 52 has a two-layer structure formed of a solid inner layer 62A passed through the center axis of the first cladding 52 and an outer layer 62B enclosing the inner layer 62A and the plurality of cores 51 with no gap. A refractive index n1 of the core 51 is provided higher than refractive indexes n2A and n2B of the inner layer 62A and the outer layer 62B, the refractive indexes n2A and n2B of the inner layer 62A and the outer layer 62B are provided higher than a refractive index n3 of the second cladding 53, and the refractive index n2A of the inner layer 62A is provided lower than the refractive index n2B of the outer layer 62B.
Abstract:
An objective of invention is conveniently concentrating a metal in a metal ion-containing solution with high efficiency and to recover the metal from the metal ion-containing solution with high recovery efficiency. A method for concentrating or recovering a metal in a metal ion-containing solution in the present invention is the method comprising the following steps, a reduction and accumulation step to reduce the metal ion into a metal fine particle and also to accumulate the metal fine particle in the microorganism by allowing the microorganism and an electron donor B to act on a metal ion-containing solution W0 and thus to obtain a solution W1 that contains a microorganism having a metal fine particle accumulated therein; a concentration step to concentrate the solution W1 that contains the microorganism having a metal fine particle accumulated therein by a filtration membrane and thus to obtain a concentrated solution W2; and a return step to return the concentrated solution W2 to first step above and thus to circulate. Further, A device for metal concentration or recovering in the present invention comprises the following: a storage unit 2 to store the solution W1, a concentration unit 3 to concentrate the solution W1 that is transferred from the storage unit 2 by a filtration membrane, and a return unit 4 to return a concentrated solution W2 that is concentrated in the concentration unit 3 to the storage unit 2.
Abstract:
A body fat diagnostic apparatus, with which a change in the velocity of ultrasonic waves can be measured and fat can be diagnosed while suppressing the effects of a periodical change due to respiration and heartbeats of a subject, is formed of: a process unit for sequentially acquiring ultrasonic wave echo signals for a number of frames so as to form a group of B mode images; a data storage unit for storing the ultrasonic wave echo signals corresponding to the groups of B mode images; a sampling unit for sampling one frame as a standard image and another frame as a comparative image through the calculation of a cross correlation; and a velocity change analyzing unit for forming an image by calculating a change in the velocity of ultrasonic waves on the basis of the ultrasonic wave echo signals corresponding to the standard image and the comparative image.
Abstract:
An objective of the present invention is to provide the cytolethal distending toxin (CDT) of C. hyointestinalis and polynucleotides encoding it, and novel methods for detection of C. hyointestinalis using the cdt genes. The present inventors focused on the cytolethal distending toxin (CDT) of Campylobacter bacteria, and detected the cdt genes of a Campylobacter-like bacterium isolated from an enteritis patient in Thailand. The present inventors discovered a bacterial strain whose cdtB gene was amplified by common primers in C. jejuni, C. coli, and C. fetus, but not by multiplex PCR that can specifically detect the cdtA, cdtB, and cdtC genes of the three bacterial species. The bacterial strain was identified as C. hyointestinalis by 16S rRNA gene analysis. Furthermore, the entire nucleotide sequence of the cdt genes was determined by genome walking upstream and downstream of the cdtB gene.
Abstract:
A composite positive electrode active material for an all-solid-state secondary battery containing particles of a positive electrode active material and a sulfide-based solid electrolyte layer coating surfaces of the particles, wherein the composite positive electrode active material has an average roundness that is 1.3 times or more of that of a positive electrode active material at an inner core of the composite positive electrode active material.
Abstract:
Provided is an implement for inspection capable of measuring the concentration of a test substance with high accuracy. The implement for inspection according to the present invention is an implement for inspection used for measuring the concentration of a test substance that includes a compound for reacting with a test substance to form a granular substance or a compound which is for being bound to the test substance and is a granular substance, and a wall portion having a periodic structure on its surface.
Abstract:
[Problem] Provided is a non-peptide compound which can be used as a GAPDH aggregation inhibitor. [Solution] Provided is a GAPDH aggregation inhibitor including as an active ingredient a compound represented by the chemical formula 1 wherein R1, R2, and R3 are each independently a hydrogen atom, a halogen atom, or an aliphatic hydrocarbon group having a carbon number of from 1 to 10, a polysulfurized derivative thereof, or a pharmaceutically acceptable salt thereof. The present compound has a GAPDH aggregation inhibitory activity to suppress intracerebral aggregation of various proteins involved in cerebral neurodegenerative diseases, thereby contributing to improvement in various brain neurological diseases associated with aggregation of these proteins such as Alzheimer's disease, Parkinson's disease, and cerebral infarction, and prevention of advanced seriousness of these diseases.
Abstract:
The present application provides a method to recover noble metal ions by reduction with using yeast. In the method, a liquid containing noble metal ions is provided. An electron donor and yeast are added into the liquid to bring the yeast in contact with the noble metal ions to reduce the noble metal ions. The noble metal can be accumulated in a fungus body of the yeast. The electron donor can be an organic acid, a salt thereof, an alcohol and hydrogen gas.
Abstract:
The pharmaceutical composition for inhibiting expression of CD47 in tumor cells provided by the present invention contains: exosomes produced by cultured tumor cells in an amount effective for inhibiting expression of the CD47; and a pharmaceutically acceptable carrier.
Abstract:
A detection device detects an analyte that may be contained in a specimen. The detection device includes a plurality of gold nanoparticles, an optical trapping light source, an illumination light source, an objective lens, an image pick-up device, and a computation unit. The plurality of gold nanoparticles are each modified with a probe DNA allowing the analyte to specifically adhere thereto. The optical trapping light source emits polarized light for assembling the plurality of gold nanoparticles together. The objective lens focuses and introduces the polarized light into a liquid containing a specimen and the plurality of gold nanoparticles. The image pick-up device receives light from the liquid. The computation unit detects an analyte based on a signal received from the image pick-up device.